No. 23A565
Liquidia Technologies, Inc. v. United Therapeutics Corporation
Tags: administrative-preclusion biotechnology-patents inter-partes-review issue-estoppel patent-infringement patent-validity
Latest Conference:
N/A
Question Presented (from Petition)
Question not identified.
Question Presented (AI Summary)
Whether a Patent Trial and Appeal Board (PTAB) decision finding patent claims unpatentable can serve as a defense to induced patent infringement before the administrative decision becomes final on appeal
Docket Entries
2023-12-20
Application (23A565) granted by The Chief Justice extending the time to file until January 24, 2024.
2023-12-15
Application (23A565) to extend the time to file a petition for a writ of certiorari from December 25, 2023 to January 24, 2024, submitted to The Chief Justice.
Attorneys
Liquidia Technologies Inc.
Kathleen Roberta Hartnett — Cooley LLP, Petitioner